Locations
Ann Arbor, MI, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series C+
founded in
2016
Strata Oncology is a precision oncology company focused on enhancing cancer treatment through advanced algorithmic biomarkers for antibody-drug conjugates and immunotherapy. Their innovative solutions, such as the Immunotherapy Response Score and Antibody-drug Conjugate Treatment Response Scores, enable healthcare providers to predict patient responses to therapies, thereby improving treatment outcomes. With a commitment to patient-centric care, Strata Oncology aims to accelerate the impact of precision medicine, ensuring that every patient receives the most effective therapy available. The company has achieved SOC 2 compliance, demonstrating its dedication to data security and privacy, positioning itself as a leader in the precision oncology market.
Something looks off?On-site & Remote